Latest

09:27
【TONGBO files for listing on HKEX: the world's 10th largest electrolytic copper foil producer by 2025 sales volume】NewTimeSpace News: On 31 August 2026, Jiangxi Tongbo Technology Co., Ltd. filed its listing application with HKEX, with Sinolink Securities (Hong Kong) as the sole sponsor; according to Frost & Sullivan, the Company was the world's 10th largest electrolytic copper foil producer by 2025 sales volume with a market share of approximately 2.3%, and is strategically focusing on RTF and HVLP electronic circuit copper foil for the AI and high-performance computing industry.
09:25
【IPLUSMOBOT (HKEX Filing): Among global top 10 intelligent mobile robot companies by 2025 revenue】NewTimeSpace News: On 31 August 2026, Zhejiang IPLUSMOBOT Technology Co., Ltd. filed its listing application with HKEX, with CICC as the sole sponsor; according to CIC, by 2025 revenue the Company ranked among the global top 10 intelligent mobile robot companies, and among the global top 5 domestic companies in the industrial intelligent mobile robot segment.
Tag： IPLUSMOBOTIPOfile a listing application
09:19
【ANEW HEALTH (HKEX Filing): "Functional Regeneration" pain management provider files for listing】NewTimeSpace News: On 31 August 2026, Anew Health Limited filed its listing application with HKEX, with VBG Capital Limited as the sole sponsor; the Company provides non-surgical, non-invasive and non-pharmaceutical pain management services in Hong Kong under the "Functional Regeneration" brand, operating three service centres in Causeway Bay, Tsim Sha Tsui and Sha Tin, each of approximately 18,000 square feet.
Tag： ANEW HEALTHIPOfile a listing application
09:15
【SUNNY SMART AUTOTECH (HKEX Filing): World's No.1 in automotive cameras by shipments files for listing】NewTimeSpace News: On 31 August 2026, Ningbo Sunny Smart Autotech Company Limited filed its listing application with HKEX, with CICC and CITIC Securities as joint sponsors; according to Frost & Sullivan, the Company ranked first globally in automotive camera products by 2025 shipment volume, with a market share equivalent to the combined share of the two next-ranked competitors, and its automotive lens groups have ranked first globally in market share for 14 consecutive years.
Tag： SUNNY SMART AUTOTECHIPOfile a listing application
09:12
【ProteLight files for HKEX listing with world's first NDA-approved FIC gana-based drug】NewTimeSpace News: On 31 August 2026, ProteLight Pharmaceuticals (Jiangsu) Co., Ltd. filed its listing application with HKEX, with CITIC Securities as the sole sponsor; its core product PL-5 is the world's first NDA-approved first-in-class gana-based drug, having received NMPA approval in June 2026 for the treatment of secondary infections of burn wounds, with plans to expand into indications including diabetic foot infections.
Tag： ProteLightIPOfile a listing application
09:07
【VONGROUP (00318.HK): FY2026 results expected before mid-September, trading remains suspended】NewTimeSpace News: On 31 August 2026, VONGROUP (00318.HK) announced that its FY2026 annual results are expected to be published before mid-September 2026, with the despatch of the annual report delayed accordingly; trading in its shares has been suspended since 3 August and will remain suspended until the annual results are published.
Tag： VONGROUP00318.HKDelay
09:05
【BIDU-SW (09888.HK): Conversion to dual-primary listing takes effect, HK shares and ADSs remain interchangeable】NewTimeSpace News: On 1 September 2026, BIDU-SW (09888.HK) announced that the conversion of its voluntary change from secondary listing to dual-primary listing has taken effect, with the Company now dual-primary listed on the Hong Kong Stock Exchange and the Nasdaq Global Select Market, and its ordinary shares and ADSs remain interchangeable.
Tag： BIDU-SW09888.HKdual-primary listing
09:04
【LAEKNA-B (02105.HK): First subject enrolled in Phase I clinical study of LAE118 for advanced solid tumours】NewTimeSpace News: On 1 September 2026, LAEKNA-B (02105.HK) announced that the first subject has been enrolled in the Phase I clinical study of LAE118, a novel PI3Kα pan-mutation selective inhibitor, for advanced solid tumours in China; the drug has received IND approval from the US FDA and CDE, and in June 2026 the Group entered into an exclusive licence agreement with Vasque Bio providing for payments of up to USD 527 million.
Tag： LAEKNA-B02105.HKClinical Trial
09:02
【ASCLETIS-B(01672.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 319.67 million, loss widened by 263.46% YoY】NewTimeSpace (newtimespace.com) News, August 31, 2026, ASCLETIS-B(01672.HK) released its Interim Report for the period ended December 31, 2026
Tag： ASCLETIS-B01672.HKNewTimeSpace
09:02
【VENUS MEDTECH-B(02500.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 191.31 million, loss widened by 41.95% YoY】NewTimeSpace (newtimespace.com) News, August 31, 2026, VENUS MEDTECH-B(02500.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 135.5 million, decreased by 27.59% YoY
Tag： VENUS MEDTECH-B02500.HKNewTimeSpace
09:02
【WK GROUP(02535.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 11.52 million, turned into a loss from a profit YoY】NewTimeSpace (newtimespace.com) News,August 31, 2026, WK GROUP(02535.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 87.76 million, decreased by 46.98% YoY
Tag： WK GROUP02535.HKNewTimeSpace
09:02
【AGILE GROUP(03383.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 8.83 billion, loss widened by 9.96% YoY】NewTimeSpace (newtimespace.com) News, August 31, 2026, AGILE GROUP(03383.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 10.86 billion, decreased by 19.99% YoY
Tag： AGILE GROUP03383.HKNewTimeSpace
09:02
【CLOUDBREAK-B(02592.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of USD 47.95 million, turned into a loss from a profit YoY】NewTimeSpace (newtimespace.com) News, August 31, 2026, CLOUDBREAK-B(02592.HK) released its Interim Report for the period ended December 31, 2026
Tag： CLOUDBREAK-B02592.HKNewTimeSpace
09:02
【GOLDEN THROAT(06896.HK)2026 Interim Report - Profit Attributable to Shareholders stood at CNY 47.61 million, YoY decrease of 43.1%】NewTimeSpace (newtimespace.com) News,August 31, 2026, GOLDEN THROAT(06896.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 280.13 million, decreased by 12.25% YoY
Tag： GOLDEN THROAT06896.HKNewTimeSpace
09:01
【China’s Largest Power‑Generation Engine Supplier! Yuchai Marine & Genset Power Refiles for Hong Kong IPO】Newtimespace News: Guangxi Yuchai Marine and Genset Power Co., Ltd. refiled its listing application with the Hong Kong Stock Exchange on 31 August, with China Merchants Securities (International) and China Galaxy International acting as joint sponsors. According to Frost & Sullivan, the company ranked first in China by sales revenue of power‑generation engines in 2025, and second for medium‑ and high‑speed marine engines over the same period. Its overseas sales surged 120.5% year‑on‑year in the first half of 2026.
Tag： Yuchai MarineIPOfile a listing application
08:59
【CSPC PHARMA (01093.HK): Phase I clinical trial of SYH2092 for weight management initiated in China】NewTimeSpace News: On 31 August 2026, CSPC PHARMA (01093.HK) announced that the Phase I clinical trial of SYH2092 injection, an amylin receptor agonist for weight management in adults who are overweight or obese, has been formally initiated at the first clinical trial centre in China, following the drug clinical trial approval notice obtained from the National Medical Products Administration in August 2026.
Tag： CSPC PHARMA01093.HKClinical Trial
08:57
【WAI CHUN BIOTEC (00660.HK): Discloses details of Malaysia AI data centre project, formal agreement pending】NewTimeSpace News: On 31 August 2026, WAI CHUN BIOTEC (00660.HK) disclosed further details at the request of the Stock Exchange on its AI data centre project at the Pahang Aerospace City in Malaysia, which will proceed in two phases with Phase 1 expected to take approximately 12 to 36 months to construct and commission; the MOU is not legally binding except for confidentiality and exclusivity provisions, and a formal agreement has yet to be signed.
Tag： WAI CHUN BIOTEC00660.HKstrategic cooperation
08:55
【SHEIN-W (00625.HK): Final offer price set at HKD 48.56 per share, trading to commence on 1 September】NewTimeSpace News: On 31 August 2026, SHEIN-W (00625.HK) announced a final offer price of HKD 48.56 per share for its global offering, with trading to commence on 1 September in board lots of 100 shares; the Hong Kong public offering was 5.63 times subscribed, and net proceeds are approximately HKD 13,214.1 million.
Tag： SHEIN-W00625.HKIPOListing
08:51
【SHIFANG HLDG (01831.HK): Shares of several shareholder companies allegedly transferred without authorisation, trading remains suspended】NewTimeSpace News: On 31 August 2026, SHIFANG HLDG (01831.HK) announced that shares of several shareholder companies were allegedly transferred without authorisation, with the company seals on the transfer documents visibly different from those on file; the Company has reported the matter to the Hong Kong police, and trading in its shares has been suspended since 24 August and will continue to be suspended.
Tag： SHIFANG HLDG01831.HKSuspected TheftSuspension
08:46
【CHAMPION TECH (00092.HK): Auditor may disclaim opinion on FY2026 financial statements, placing terminated】NewTimeSpace News: On 31 August 2026, CHAMPION TECH (00092.HK) announced that its auditors may disclaim an opinion on the going concern matter in its FY2026 financial statements, with losses expected to be more severe than the same period in 2025, and the placing of up to 84,024,000 new shares was immediately terminated on the same day.
Tag： CHAMPION TECH00092.HKTermination of Placing
Previous1..1213 141516..493     493 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments